Skip to content

Drug interactions

Cobicistat + Sunitinib

Severity: Major

Cobicistat and Sunitinib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat is a strong CYP3A4 inhibitor and can substantially raise sunitinib and its active metabolite levels, increasing toxicities such as hepatotoxicity, QT prolongation and myelosuppression.

What this interaction means in plain words

Cobicistat and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Cobicistat belongs to Miscellaneous; Sunitinib belongs to Oncology.

Evidence level: High

Why it happens

Cobicistat inhibits CYP3A4, reducing sunitinib metabolism.

What to do

Avoid if possible; otherwise lower the sunitinib dose per labeling for strong CYP3A4 inhibitors and monitor for toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobicistat and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Cobicistat with Sunitinib?

MediHelp rates the interaction as major. Cobicistat and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cobicistat is a strong CYP3A4 inhibitor and can substantially raise sunitinib and its active metabolite levels, increasing toxicities such as hepatotoxicity, QT prolongation and myelosuppression.

How serious is the interaction between Cobicistat and Sunitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; otherwise lower the sunitinib dose per labeling for strong CYP3A4 inhibitors and monitor for toxicity.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in